Mark Theeuwes - Chief Operating Officer

Professional Overview

Mark Theeuwes is a seasoned pharmaceutical executive with extensive experience in operations, strategic planning, and business development. As the Chief Operating Officer at Reunion Neuroscience and a Strategic Advisor at Somnia Therapeutics, he leverages his deep industry knowledge to drive organizational growth and innovation.

Current Roles

Chief Operating Officer, Reunion Neuroscience (2023-08-01 to Present)

• Responsible for overseeing the day-to-day operations of the company, including manufacturing, supply chain, and quality assurance

• Spearheading the implementation of efficient processes and systems to optimize operational efficiency

• Collaborating with the executive team to develop and execute strategic initiatives that align with the company's long-term goals

Strategic Advisor, Somnia Therapeutics (2023-09-01 to Present)

• Providing strategic guidance and industry expertise to support the development and commercialization of Somnia's novel therapeutic solutions

• Advising on key business decisions and collaborating with the leadership team to identify and capitalize on market opportunities

Member, Board of Directors, Epilepsy Foundation (2022-07-01 to Present)

• Serving on the board of directors to help shape the organization's strategic direction and support its mission to improve the lives of people living with epilepsy

Principal, Pharmaceutical Services, LLC (2018-06-01 to Present)

• Leveraging his extensive industry knowledge to provide consulting services to pharmaceutical companies on a range of operational and strategic initiatives

Career Progression

Prior to his current roles, Mark held several senior-level positions within the pharmaceutical industry, including:

• President and Chief Executive Officer, Receptor Life Sciences, Inc. (2021-01-01 to 2023-04-01)

• Chief Operating Officer, Engage Therapeutics (2019-05-01 to 2020-08-01)

• Vice President, External Operations, Engage Therapeutics (2018-10-01 to 2019-05-01)

• Vice President, Sales, Trade Relations, and Commercial Operations, Egalet Corporation (2016-09-01 to 2018-06-01)

• Vice President, Analytics, Egalet Corporation (2015-06-01 to 2016-09-01)

• Executive Director, Business Information and Decision Support, NPS Pharmaceuticals (2014-04-01 to 2015-06-01)

Academic Background

Mark holds a Bachelor of Science degree in Business Administration from the University of Delaware.

Areas of Expertise

• Pharmaceutical operations and supply chain management

• Strategic planning and business development

• Commercial and analytics-driven decision making

• Regulatory compliance and quality assurance

• Cross-functional team leadership and collaboration

Professional Impact

Throughout his career, Mark has demonstrated a proven track record of driving operational excellence, implementing innovative solutions, and delivering measurable results. His deep industry expertise and strategic mindset have enabled him to contribute significantly to the growth and success of the organizations he has served.

Conclusion

With his extensive experience in the pharmaceutical industry and a proven ability to enhance operational efficiency and drive strategic initiatives, Mark Theeuwes is well-positioned to continue making a lasting impact as a respected industry leader.